• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Letter-to-the-editor on "A low-carbohydrate diet induces hepatic insulin resistance and metabolic associated fatty liver disease in mice".致编辑的信：关于“低碳水化合物饮食诱导小鼠肝脏胰岛素抵抗和代谢相关脂肪性肝病”
Mol Metab. 2024 Mar;81:101898. doi: 10.1016/j.molmet.2024.101898. Epub 2024 Feb 13.
2
Response-to Letter-to-the-editor: "A low-carbohydrate diet induces hepatic insulin resistance and metabolic associated fatty liver disease in mice".致编辑信的回复：“低碳水化合物饮食诱导小鼠肝脏胰岛素抵抗和代谢相关脂肪性肝病”
Mol Metab. 2024 Mar;81:101897. doi: 10.1016/j.molmet.2024.101897. Epub 2024 Feb 13.
3
A low-carbohydrate diet induces hepatic insulin resistance and metabolic associated fatty liver disease in mice.低碳水化合物饮食可诱导小鼠肝胰岛素抵抗和代谢相关脂肪性肝病。
Mol Metab. 2023 Mar;69:101675. doi: 10.1016/j.molmet.2023.101675. Epub 2023 Jan 19.
4
Effects of a carbohydrate-restricted diet on hepatic lipid content in adolescents with non-alcoholic fatty liver disease: A pilot, randomized trial.低碳水化合物饮食对非酒精性脂肪性肝病青少年肝脏脂质含量的影响：一项初步随机试验。
Pediatr Obes. 2020 Jul;15(7):e12630. doi: 10.1111/ijpo.12630. Epub 2020 Mar 4.
5
Inhibition of citrate cotransporter Slc13a5/mINDY by RNAi improves hepatic insulin sensitivity and prevents diet-induced non-alcoholic fatty liver disease in mice.RNAi 抑制柠檬酸共转运蛋白 Slc13a5/mINDY 可改善小鼠肝脏胰岛素敏感性并预防饮食诱导的非酒精性脂肪肝。
Mol Metab. 2016 Aug 13;5(11):1072-1082. doi: 10.1016/j.molmet.2016.08.004. eCollection 2016 Nov.
6
Reply-Letter to the Editor: Critical appraisal for low-carbohydrate diet in nonalcoholic fatty liver disease.致编辑的回信：对非酒精性脂肪性肝病中低碳水化合物饮食的批判性评价
Clin Nutr. 2020 Jan;39(1):306. doi: 10.1016/j.clnu.2019.11.029. Epub 2019 Nov 25.
7
Dissociation of hepatic insulin resistance from susceptibility of nonalcoholic fatty liver disease induced by a high-fat and high-carbohydrate diet in mice.高脂高糖饮食诱导的小鼠非酒精性脂肪性肝病中肝胰岛素抵抗与易感性的分离。
Am J Physiol Gastrointest Liver Physiol. 2014 Mar;306(6):G496-504. doi: 10.1152/ajpgi.00291.2013. Epub 2014 Jan 16.
8
Letter to the editor about "the effect of a fruit-rich diet on liver biomarkers, insulin resistance, and lipid profile in patients with non-alcoholic fatty liver disease: a randomized clinical trial".致编辑的信：关于“富含水果的饮食对非酒精性脂肪性肝病患者肝脏生物标志物、胰岛素抵抗和血脂谱的影响：一项随机临床试验”
Scand J Gastroenterol. 2023 Feb;58(2):222. doi: 10.1080/00365521.2022.2114808. Epub 2022 Aug 29.
9
Effectiveness of a carbohydrate restricted diet to treat non-alcoholic fatty liver disease in adolescents with obesity: Trial design and methodology.低碳水化合物饮食治疗肥胖青少年非酒精性脂肪性肝病的有效性：试验设计与方法
Contemp Clin Trials. 2018 May;68:95-101. doi: 10.1016/j.cct.2018.03.014. Epub 2018 Mar 27.
10
Baseline HOMA IR and Circulating FGF21 Levels Predict NAFLD Improvement in Patients Undergoing a Low Carbohydrate Dietary Intervention for Weight Loss: A Prospective Observational Pilot Study.基线 HOMA-IR 和循环 FGF21 水平可预测接受低碳水化合物饮食干预减肥的非酒精性脂肪性肝病患者的改善：一项前瞻性观察性初步研究。
Nutrients. 2020 Jul 18;12(7):2141. doi: 10.3390/nu12072141.

本文引用的文献

1
Weight, insulin resistance, blood lipids, and diet quality changes associated with ketogenic and ultra low-fat dietary patterns: a secondary analysis of the DIETFITS randomized clinical trial.与生酮饮食和极低脂肪饮食模式相关的体重、胰岛素抵抗、血脂及饮食质量变化：DIETFITS随机临床试验的二次分析
Front Nutr. 2023 Jul 12;10:1220020. doi: 10.3389/fnut.2023.1220020. eCollection 2023.
2
Very low-calorie ketogenic diet: A valuable and fashionable nutritional therapy. When could it become dangerous?极低热量生酮饮食：一种有价值且时尚的营养疗法。它何时会变得危险？
Diabetes Metab Res Rev. 2023 Nov;39(8):e3698. doi: 10.1002/dmrr.3698. Epub 2023 Jul 19.
3
A low-carbohydrate diet induces hepatic insulin resistance and metabolic associated fatty liver disease in mice.低碳水化合物饮食可诱导小鼠肝胰岛素抵抗和代谢相关脂肪性肝病。
Mol Metab. 2023 Mar;69:101675. doi: 10.1016/j.molmet.2023.101675. Epub 2023 Jan 19.
4
Importance of temperature on immuno-metabolic regulation and cancer progression.温度对免疫代谢调节和癌症进展的重要性。
FEBS J. 2024 Mar;291(5):832-845. doi: 10.1111/febs.16632. Epub 2022 Oct 2.
5
Current Evidence Concerning Effects of Ketogenic Diet and Intermittent Fasting in Patients with Nonalcoholic Fatty Liver.关于生酮饮食和间歇性禁食对非酒精性脂肪肝患者影响的当前证据
J Clin Transl Hepatol. 2022 Aug 28;10(4):730-739. doi: 10.14218/JCTH.2021.00494. Epub 2022 May 6.
6
The ketogenic diet prevents steatosis and insulin resistance by reducing lipogenesis, diacylglycerol accumulation and protein kinase C activity in male rat liver.生酮饮食可通过减少脂肪生成、二酰基甘油积累和蛋白激酶 C 活性来预防雄性大鼠肝脏脂肪变性和胰岛素抵抗。
J Physiol. 2022 Sep;600(18):4137-4151. doi: 10.1113/JP283552. Epub 2022 Sep 4.
7
Ketogenic Diets and Chronic Disease: Weighing the Benefits Against the Risks.生酮饮食与慢性病：权衡利弊
Front Nutr. 2021 Jul 16;8:702802. doi: 10.3389/fnut.2021.702802. eCollection 2021.
8
European Guidelines for Obesity Management in Adults with a Very Low-Calorie Ketogenic Diet: A Systematic Review and Meta-Analysis.欧洲极低卡路里生酮饮食成人肥胖管理指南：系统评价和荟萃分析。
Obes Facts. 2021;14(2):222-245. doi: 10.1159/000515381. Epub 2021 Apr 21.
9
The management of very low-calorie ketogenic diet in obesity outpatient clinic: a practical guide.肥胖门诊极低卡路里生酮饮食管理：实用指南。
J Transl Med. 2019 Oct 29;17(1):356. doi: 10.1186/s12967-019-2104-z.
10
Review of current evidence and clinical recommendations on the effects of low-carbohydrate and very-low-carbohydrate (including ketogenic) diets for the management of body weight and other cardiometabolic risk factors: A scientific statement from the National Lipid Association Nutrition and Lifestyle Task Force.当前有关低碳水化合物和极低碳水化合物（包括生酮）饮食对体重和其他心血管代谢风险因素管理影响的证据和临床推荐综述：来自国家脂质协会营养与生活方式工作组的科学声明。
J Clin Lipidol. 2019 Sep-Oct;13(5):689-711.e1. doi: 10.1016/j.jacl.2019.08.003. Epub 2019 Sep 13.

Letter-to-the-editor on "A low-carbohydrate diet induces hepatic insulin resistance and metabolic associated fatty liver disease in mice".

作者信息

Wang Xin, Jiang Bo

机构信息

Beijing Tiantan Hospital, Capital Medical University, China; Beijing Shijitan Hospital, Capital Medical University, China.

Beijing Tiantan Hospital, Capital Medical University, China.

出版信息

Mol Metab. 2024 Mar;81:101898. doi: 10.1016/j.molmet.2024.101898. Epub 2024 Feb 13.

DOI:10.1016/j.molmet.2024.101898
PMID:38360108
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10928363/
Abstract
摘要